nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—gallbladder cancer	0.944	1	CbGaD
Lidocaine—SCN5A—L1CAM interactions—EGFR—gallbladder cancer	0.000185	0.00333	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—ERBB3—gallbladder cancer	0.000184	0.00332	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—ERBB3—gallbladder cancer	0.000183	0.0033	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—ERBB4—gallbladder cancer	0.000182	0.00329	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—ERBB3—gallbladder cancer	0.000182	0.00329	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—ERBB3—gallbladder cancer	0.000181	0.00327	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—KRAS—gallbladder cancer	0.000181	0.00327	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB3—gallbladder cancer	0.000179	0.00322	CbGpPWpGaD
Lidocaine—EGFR—a6b1 and a6b4 Integrin signaling—HRAS—gallbladder cancer	0.000178	0.00321	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NRAS—gallbladder cancer	0.000177	0.00319	CbGpPWpGaD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000175	0.00316	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB4—gallbladder cancer	0.000175	0.00315	CbGpPWpGaD
Lidocaine—EGFR—PI-3K cascade—ERBB2—gallbladder cancer	0.000171	0.0031	CbGpPWpGaD
Lidocaine—EGFR—SHP2 signaling—KRAS—gallbladder cancer	0.000171	0.00308	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB3—gallbladder cancer	0.00017	0.00308	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—ERBB3—gallbladder cancer	0.00017	0.00308	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—ERBB3—gallbladder cancer	0.00017	0.00308	CbGpPWpGaD
Lidocaine—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—gallbladder cancer	0.000169	0.00305	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—ERBB3—gallbladder cancer	0.000169	0.00305	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—ERBB3—gallbladder cancer	0.000167	0.00302	CbGpPWpGaD
Lidocaine—EGFR—PI3K/AKT activation—ERBB2—gallbladder cancer	0.000167	0.00302	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—ERBB3—gallbladder cancer	0.000167	0.00301	CbGpPWpGaD
Lidocaine—EGFR—GAB1 signalosome—ERBB2—gallbladder cancer	0.000166	0.003	CbGpPWpGaD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—gallbladder cancer	0.000162	0.00293	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—ERBB2—gallbladder cancer	0.000161	0.00292	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—TP53—gallbladder cancer	0.000161	0.0029	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—ERBB3—gallbladder cancer	0.000158	0.00285	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KEAP1—gallbladder cancer	0.000155	0.0028	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—ERBB2—gallbladder cancer	0.000154	0.00279	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—HRAS—gallbladder cancer	0.000154	0.00278	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—KRAS—gallbladder cancer	0.000152	0.00275	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB3—gallbladder cancer	0.000151	0.00273	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—NRAS—gallbladder cancer	0.00015	0.00272	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—ERBB2—gallbladder cancer	0.000148	0.00268	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—ERBB2—gallbladder cancer	0.000148	0.00268	CbGpPWpGaD
Lidocaine—EGFR—SHP2 signaling—HRAS—gallbladder cancer	0.000145	0.00262	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—ERBB2—gallbladder cancer	0.000143	0.00258	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—gallbladder cancer	0.000135	0.00244	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—ERBB4—gallbladder cancer	0.000134	0.00242	CbGpPWpGaD
Lidocaine—EGFR—LPA receptor mediated events—HRAS—gallbladder cancer	0.000134	0.00242	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—BCL2—gallbladder cancer	0.000133	0.0024	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—KRAS—gallbladder cancer	0.000129	0.00234	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	0.000129	0.00234	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.000128	0.00231	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.000125	0.00225	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—NRAS—gallbladder cancer	0.000123	0.00223	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—NRAS—gallbladder cancer	0.000123	0.00222	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	0.000123	0.00221	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—ERBB2—gallbladder cancer	0.000121	0.00218	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—NRAS—gallbladder cancer	0.000118	0.00212	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—ERBB3—gallbladder cancer	0.000116	0.0021	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—ERBB2—gallbladder cancer	0.000115	0.00208	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—ERBB2—gallbladder cancer	0.000115	0.00208	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—TP53—gallbladder cancer	0.000115	0.00208	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—ERBB2—gallbladder cancer	0.000115	0.00207	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.000115	0.00207	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—ERBB2—gallbladder cancer	0.000114	0.00206	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—ERBB2—gallbladder cancer	0.000114	0.00205	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—NRAS—gallbladder cancer	0.000113	0.00204	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—NRAS—gallbladder cancer	0.000113	0.00204	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—EGFR—gallbladder cancer	0.000112	0.00202	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—gallbladder cancer	0.000112	0.00202	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—ERBB2—gallbladder cancer	0.00011	0.00199	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	0.00011	0.00199	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—NRAS—gallbladder cancer	0.000109	0.00197	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—EGFR—gallbladder cancer	0.000107	0.00193	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—ERBB2—gallbladder cancer	0.000107	0.00193	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.000107	0.00193	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.000107	0.00193	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.000106	0.00192	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—ERBB2—gallbladder cancer	0.000106	0.00191	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—ERBB2—gallbladder cancer	0.000106	0.00191	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—ERBB2—gallbladder cancer	0.000106	0.00191	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—KRAS—gallbladder cancer	0.000106	0.00191	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.000105	0.0019	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—ERBB2—gallbladder cancer	0.000104	0.00189	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—BCL2—gallbladder cancer	0.000104	0.00188	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000103	0.00187	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—EGFR—gallbladder cancer	0.000103	0.00186	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—EGFR—gallbladder cancer	0.000103	0.00186	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—ERBB2—gallbladder cancer	0.000102	0.00184	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—KRAS—gallbladder cancer	0.000101	0.00183	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—ERBB2—gallbladder cancer	0.000101	0.00182	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—ERBB2—gallbladder cancer	0.000101	0.00182	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000101	0.00182	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—EGFR—gallbladder cancer	9.92e-05	0.00179	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—ERBB2—gallbladder cancer	9.89e-05	0.00179	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—NRAS—gallbladder cancer	9.75e-05	0.00176	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—KRAS—gallbladder cancer	9.72e-05	0.00175	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—KRAS—gallbladder cancer	9.72e-05	0.00175	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	9.62e-05	0.00174	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	9.46e-05	0.00171	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KEAP1—gallbladder cancer	9.39e-05	0.0017	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—KRAS—gallbladder cancer	9.37e-05	0.00169	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	9.33e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	9.33e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—NRAS—gallbladder cancer	9.18e-05	0.00166	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—HRAS—gallbladder cancer	9.03e-05	0.00163	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—HRAS—gallbladder cancer	8.99e-05	0.00162	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	8.77e-05	0.00158	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	8.77e-05	0.00158	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—NRAS—gallbladder cancer	8.77e-05	0.00158	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—NRAS—gallbladder cancer	8.77e-05	0.00158	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—NRAS—gallbladder cancer	8.72e-05	0.00158	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—NRAS—gallbladder cancer	8.68e-05	0.00157	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—NRAS—gallbladder cancer	8.64e-05	0.00156	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—gallbladder cancer	8.6e-05	0.00155	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—HRAS—gallbladder cancer	8.6e-05	0.00155	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	8.52e-05	0.00154	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—NRAS—gallbladder cancer	8.47e-05	0.00153	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—KRAS—gallbladder cancer	8.39e-05	0.00152	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—NRAS—gallbladder cancer	8.39e-05	0.00151	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	8.28e-05	0.0015	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—HRAS—gallbladder cancer	8.26e-05	0.00149	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—HRAS—gallbladder cancer	8.26e-05	0.00149	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—NRAS—gallbladder cancer	8.13e-05	0.00147	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—NRAS—gallbladder cancer	8.13e-05	0.00147	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	8.13e-05	0.00147	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—NRAS—gallbladder cancer	8.06e-05	0.00145	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—NRAS—gallbladder cancer	8.06e-05	0.00145	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—NRAS—gallbladder cancer	8.06e-05	0.00145	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	8.03e-05	0.00145	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	8.03e-05	0.00145	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—gallbladder cancer	7.99e-05	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	7.98e-05	0.00144	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—HRAS—gallbladder cancer	7.96e-05	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—NRAS—gallbladder cancer	7.95e-05	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	7.94e-05	0.00143	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—KRAS—gallbladder cancer	7.9e-05	0.00143	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—NRAS—gallbladder cancer	7.77e-05	0.0014	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB4—gallbladder cancer	7.66e-05	0.00138	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—NRAS—gallbladder cancer	7.65e-05	0.00138	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—gallbladder cancer	7.64e-05	0.00138	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—KRAS—gallbladder cancer	7.55e-05	0.00136	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—KRAS—gallbladder cancer	7.55e-05	0.00136	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—NRAS—gallbladder cancer	7.52e-05	0.00136	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	7.51e-05	0.00136	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—KRAS—gallbladder cancer	7.51e-05	0.00136	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—gallbladder cancer	7.5e-05	0.00135	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—KRAS—gallbladder cancer	7.47e-05	0.00135	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—KRAS—gallbladder cancer	7.44e-05	0.00134	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB4—gallbladder cancer	7.35e-05	0.00133	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—gallbladder cancer	7.34e-05	0.00133	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—gallbladder cancer	7.34e-05	0.00133	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	7.33e-05	0.00132	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—KRAS—gallbladder cancer	7.29e-05	0.00132	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—ERBB2—gallbladder cancer	7.28e-05	0.00131	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—KRAS—gallbladder cancer	7.22e-05	0.0013	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	7.2e-05	0.0013	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—ERBB2—gallbladder cancer	7.18e-05	0.0013	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—HRAS—gallbladder cancer	7.13e-05	0.00129	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—gallbladder cancer	7.08e-05	0.00128	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	7.06e-05	0.00127	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	7.04e-05	0.00127	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—KRAS—gallbladder cancer	7e-05	0.00126	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—KRAS—gallbladder cancer	7e-05	0.00126	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	7e-05	0.00126	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—gallbladder cancer	6.97e-05	0.00126	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	6.96e-05	0.00126	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—KRAS—gallbladder cancer	6.93e-05	0.00125	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—KRAS—gallbladder cancer	6.93e-05	0.00125	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—KRAS—gallbladder cancer	6.93e-05	0.00125	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	6.87e-05	0.00124	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—KRAS—gallbladder cancer	6.84e-05	0.00124	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	6.82e-05	0.00123	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—HRAS—gallbladder cancer	6.72e-05	0.00121	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—KRAS—gallbladder cancer	6.69e-05	0.00121	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB3—gallbladder cancer	6.62e-05	0.0012	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—KRAS—gallbladder cancer	6.59e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—ERBB2—gallbladder cancer	6.59e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	6.58e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—gallbladder cancer	6.48e-05	0.00117	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—KRAS—gallbladder cancer	6.47e-05	0.00117	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—HRAS—gallbladder cancer	6.41e-05	0.00116	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HRAS—gallbladder cancer	6.41e-05	0.00116	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—HRAS—gallbladder cancer	6.38e-05	0.00115	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	6.38e-05	0.00115	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB3—gallbladder cancer	6.36e-05	0.00115	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—HRAS—gallbladder cancer	6.35e-05	0.00115	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—HRAS—gallbladder cancer	6.32e-05	0.00114	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	6.23e-05	0.00112	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	6.2e-05	0.00112	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HRAS—gallbladder cancer	6.13e-05	0.00111	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	5.99e-05	0.00108	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—gallbladder cancer	5.95e-05	0.00107	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—gallbladder cancer	5.95e-05	0.00107	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	5.95e-05	0.00107	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—gallbladder cancer	5.89e-05	0.00106	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—gallbladder cancer	5.89e-05	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—gallbladder cancer	5.89e-05	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	5.85e-05	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	5.84e-05	0.00105	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—gallbladder cancer	5.82e-05	0.00105	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—gallbladder cancer	5.68e-05	0.00103	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—gallbladder cancer	5.62e-05	0.00101	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—gallbladder cancer	5.6e-05	0.00101	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—NRAS—gallbladder cancer	5.54e-05	0.001	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—gallbladder cancer	5.5e-05	0.000994	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NRAS—gallbladder cancer	5.46e-05	0.000986	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	5.27e-05	0.000951	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	5.22e-05	0.000943	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	5.09e-05	0.000919	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	5.07e-05	0.000916	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—NRAS—gallbladder cancer	5.01e-05	0.000905	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—gallbladder cancer	4.98e-05	0.000899	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—KRAS—gallbladder cancer	4.77e-05	0.000861	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—KRAS—gallbladder cancer	4.7e-05	0.000849	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—ERBB2—gallbladder cancer	4.7e-05	0.000849	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB4—gallbladder cancer	4.46e-05	0.000805	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—KRAS—gallbladder cancer	4.31e-05	0.000779	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—BCL2—gallbladder cancer	4.27e-05	0.000772	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB2—gallbladder cancer	4.15e-05	0.00075	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB4—gallbladder cancer	4.12e-05	0.000744	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—gallbladder cancer	4.05e-05	0.000731	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—gallbladder cancer	4e-05	0.000722	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB2—gallbladder cancer	3.99e-05	0.00072	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB3—gallbladder cancer	3.86e-05	0.000696	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—gallbladder cancer	3.67e-05	0.000662	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NRAS—gallbladder cancer	3.58e-05	0.000646	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB3—gallbladder cancer	3.56e-05	0.000643	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	3.52e-05	0.000635	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	3.32e-05	0.0006	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NRAS—gallbladder cancer	3.16e-05	0.00057	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KRAS—gallbladder cancer	3.08e-05	0.000556	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NRAS—gallbladder cancer	3.03e-05	0.000548	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	2.95e-05	0.000533	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB4—gallbladder cancer	2.88e-05	0.000521	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KRAS—gallbladder cancer	2.72e-05	0.000491	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—gallbladder cancer	2.62e-05	0.000472	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KRAS—gallbladder cancer	2.61e-05	0.000471	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB3—gallbladder cancer	2.49e-05	0.00045	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BCL2—gallbladder cancer	2.49e-05	0.000449	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB2—gallbladder cancer	2.42e-05	0.000437	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—gallbladder cancer	2.31e-05	0.000417	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB2—gallbladder cancer	2.23e-05	0.000403	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—gallbladder cancer	2.22e-05	0.000401	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—gallbladder cancer	2.01e-05	0.000364	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—gallbladder cancer	1.84e-05	0.000332	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—gallbladder cancer	1.73e-05	0.000313	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—gallbladder cancer	1.7e-05	0.000307	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—gallbladder cancer	1.58e-05	0.000286	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—gallbladder cancer	1.56e-05	0.000282	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—gallbladder cancer	1.47e-05	0.000266	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—gallbladder cancer	1.46e-05	0.000264	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—gallbladder cancer	1.35e-05	0.000243	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—gallbladder cancer	1.24e-05	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—gallbladder cancer	1.19e-05	0.000215	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—gallbladder cancer	1.02e-05	0.000185	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—gallbladder cancer	9.1e-06	0.000164	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—gallbladder cancer	8.7e-06	0.000157	CbGpPWpGaD
